AMENDED AND RESTATED EMPLOYMENT AGREEMENT by and between Reata Pharmaceuticals, Inc. and Jason D. WilsonEmployment Agreement • June 23rd, 2017 • Reata Pharmaceuticals Inc • Pharmaceutical preparations • Texas
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of June 14, 2017, by and between Reata Pharmaceuticals, Inc., a Delaware corporation (together with its successors and assigns permitted hereunder, the “Company”), and Jason D. Wilson (the “Executive”).
SECOND SUPPLEMENT TO EXCLUSIVE LICENSE AND SUPPLY AGREEMENTExclusive License and Supply Agreement • June 23rd, 2017 • Reata Pharmaceuticals Inc • Pharmaceutical preparations
This Second Supplement (herein so called), effective as of March 21, 2017 (the “Supplement Effective Date”), to the Exclusive License and Supply Agreement, effective as of December 24, 2009 (the “Original Agreement), is by and between Reata Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware, USA, with an address at 2801 Gateway Drive, Suite 150, Irving, Texas 75063 (“Reata”), and Kyowa Hakko Kirin Co., Ltd., a company organized and existing under the laws of Japan, with an address at 1-9-2 Ohtemachi, Chiyoda-ku, Tokyo, 100-0004, Japan (“Kyowa Kirin”). Reata and Kyowa Kirin are sometimes hereinafter referred to each as a “Party” and collectively as the “Parties”.
